Search for: "McNeil v. Post et al"
Results 1 - 20
of 29
Sorted by Relevance
|
Sort by Date
2 Oct 2017, 11:37 am
McNeil, et al. v. [read post]
24 Nov 2010, 10:57 am
Johnson & Johnson, et al. [read post]
21 Jan 2007, 10:48 pm
All opinions are precedential unless otherwise indicated.Transclean Corporation et al. v. [read post]
16 Jun 2023, 9:30 pm
We spotted the Brief for American Historical Association et al. as Amici Curiae cited on page 4 (h/t Gautham Rao, Maggie Blackhawk). [read post]
28 Jul 2010, 12:06 am
K-V Pharmaceutical Co. et al. [read post]
27 May 2010, 3:20 am
Idexx Reference Laboratories, Inc. et al.; Pieczenik v. [read post]
15 Jan 2008, 3:06 am
Match.Com, LP et al filed 01/30/07 1:07-cv-00591 Guan Gao Company, Ltd. et al v. [read post]
20 May 2009, 5:18 am
: Dr Reddy’s post grant opposition against Pfizer’s Champix patent (Spicy IP) Tanzania generic pharma sector set for growth (Afro-IP) US: ACLU, PUBPAT and others file lawsuit challenging constitutionality of patents on human genes associated with breast and ovarian cancer: Association for Molecular Pathology et al v USPTO et al (Patent Baristas) (Ars Technica) (Patently-O) (IP Watchdog) (The Prior Art) (Patent Docs)… [read post]
16 Feb 2022, 12:32 pm
Wells Fargo Clearing Services, LLC et al., File No. 2019CV328949, Superior Court of Georgia, Fulton County (January 25, 2022). [read post]
10 Feb 2010, 11:56 am
In none of them is a claim asserted that could survive Frye, et al. [read post]
17 Nov 2010, 1:48 am
McNeil (EPLAW) Zymar (Gatifloxacin) – US: Allergan fails to secure new trial in Zymar case: Senju et al v Apotex (Patent Docs) [read post]
23 Jan 2011, 8:25 pm
Dickinson Wright and John Artz (Patently-O) (PharmaPatents) BPAI: Removing terminal disclaimers by patent reissue: Ex parte Shunpei Yamazaki (Patents Post Grant Blog) District Court N D Ohio: Equitable intervening rights: Bendix Commercial Vehicle Systems LLC, et al v. [read post]
25 Jul 2008, 2:11 am
In Ortho-McNeil Pharmaceutical, Inc. v. [read post]
1 Mar 2007, 4:57 am
OCs (Estimated Relative Risk or Odds Ratio with 95% CI) Bloemenkamp et al,[8]1995 Case-Control 2.2 (0.9-5.4) Spitzer (Transnational),[9] 1996 Case-Control 1.5 (1.1-2.2) Bloemankamp et al,[13] 1999 Case-Control 1.9 (0.8-4.5) Jick et al (UK-GPRD),[14] 2000 Cohort/Case-Control 1.9 (1.3-2.8)/2.3 (1.3-3.9) Farley et al (WHO),[6] 1995 Case-Control 2.4 (1.3-4.6) Jick et al (UK-GPRD),[7] 1995 Cohort/Case-Control 1.9… [read post]
27 Oct 2011, 4:24 am
Et cetera. [read post]
7 Feb 2021, 4:01 am
McNeil, 2009 SCC 3, [2009] 1 S.C.R. 66. [read post]
25 Mar 2016, 1:00 pm
McNeil-PPC, Inc., et al., -- F. [read post]
20 Jan 2016, 2:39 pm
Just yesterday the Supreme Court declined to accept for hearing an appeal for the case Johnson & Johnson, et al., Petitioners v. [read post]
3 Sep 2015, 6:36 am
O’Reilly, et al., 1 Food & Drug Admin. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram) –… [read post]
